Literature DB >> 468799

Characterization of a somatomedin (insulin-like growth factor) synthesized by fetal rat liver organ cultures.

M M Rechler, H J Eisen, O Z Higa, P Nissley, A C Moses, E E Schilling, I Fennoy, C B Bruni, L S Phillips, K L Baird.   

Abstract

Explants of 19- to 20-day fetal rat liver synthesize polypeptides biochemically and immunologically related to the well characterized somatomedin (insulin-like growth factor) BRL-MSA, multiplication-stimulating activity. Fetal MSA was purified from media conditioned by fetal liver explants by chromatography on Sephadex G-75 under acid conditions. Partially purified fetal MSA: 1) inhibited the binding of BRL-MSA to the MSA receptor of rat liver plasma membranes, to somatomedin-binding proteins from rat serum, and to rabbit anti-BRL-MSA serum; 2) had a molecular weight of 4,500 to 12,500 determined by polyacrylamide gel electrophoresis in sodium dodecyl sulfate; 3) stimulated the incorporation of [3H]thymidine into the DNA of chick embryo fibroblasts and induced cell multiplication; 4) stimulated glucose oxidation in rat adipocytes and weakly inhibited the binding of insulin to the insulin receptors of IM-9 lymphocytes; and 5) stimulated sulfate uptake in costal cartilage from hypophysectomized rats. These activities were associated with the same molecular species in fetal MSA preparations following disc acrylamide electrophoresis and co-migrated with active BRL-MSA peptides.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 468799

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

1.  Structural and functional characterization of the human T lymphocyte receptor for insulin-like growth factor I in vitro.

Authors:  V F Tapson; M Boni-Schnetzler; P F Pilch; D M Center; J S Berman
Journal:  J Clin Invest       Date:  1988-09       Impact factor: 14.808

2.  Placental lactogen administration reverses the effect of low-protein diet on maternal and fetal serum somatomedin levels in the pregnant rat.

Authors:  S J Pilistine; A C Moses; H N Munro
Journal:  Proc Natl Acad Sci U S A       Date:  1984-09       Impact factor: 11.205

3.  Human embryonic somatomedin.

Authors:  V R Sara; K Hall; C H Rodeck; L Wetterberg
Journal:  Proc Natl Acad Sci U S A       Date:  1981-05       Impact factor: 11.205

4.  Increased levels of multiplication-stimulating activity, an insulin-like growth factor, in fetal rat serum.

Authors:  A C Moses; S P Nissley; P A Short; M M Rechler; R M White; A B Knight; O Z Higa
Journal:  Proc Natl Acad Sci U S A       Date:  1980-06       Impact factor: 11.205

5.  Developmental pattern of a serum binding protein for multiplication stimulating activity in the rat.

Authors:  R M White; S P Nissley; P A Short; M M Rechler; I Fennoy
Journal:  J Clin Invest       Date:  1982-06       Impact factor: 14.808

6.  Decreased sensitivity of old and progeric human fibroblasts to a preparation of factors with insulinlike activity.

Authors:  C B Harley; S Goldstein; B I Posner; H Guyda
Journal:  J Clin Invest       Date:  1981-10       Impact factor: 14.808

7.  Direct demonstration of separate receptors for growth and metabolic activities of insulin and multiplication-stimulating activity (an insulinlike growth factor) using antibodies to the insulin receptor.

Authors:  G L King; C R Kahn; M M Rechler; S P Nissley
Journal:  J Clin Invest       Date:  1980-07       Impact factor: 14.808

8.  Hormonal control of immunoreactive somatomedin production by cultured human fibroblasts.

Authors:  D R Clemmons; L E Underwood; J J Van Wyk
Journal:  J Clin Invest       Date:  1981-01       Impact factor: 14.808

9.  FGF, Insulin, and SMAD Signaling Cooperate for Avian Primordial Germ Cell Self-Renewal.

Authors:  Jemima Whyte; James D Glover; Mark Woodcock; Joanna Brzeszczynska; Lorna Taylor; Adrian Sherman; Pete Kaiser; Michael J McGrew
Journal:  Stem Cell Reports       Date:  2015-11-19       Impact factor: 7.765

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.